🔥 This breakthrough could revolutionize obesity research and lead to long-term effects in obese patients.
🐭 The researchers found that blocking a specific enzyme fragment called AC3-AT in brown fat cells helped mice combat obesity and increase their metabolic rates.
💡 The team believes this finding could pave the way for therapies that activate brown fat and tackle obesity in humans.
👩🔬 Further research is needed to understand the therapeutic impact of this discovery and other regulatory mechanisms in brown fat cells.
Introduction:
A German-Danish research team has discovered a new way to combat obesity by targeting brown fat cells. The researchers found that a truncated version of the enzyme adenylate cyclase 3 can be used to convert fat-storing white adipocytes into fat-burning brown adipocytes. If this principle also applies in humans, it could lead to the development of therapeutics that regulate the activity of the enzyme fragment and help combat obesity (Nature Metabolism, doi 10.1038/s42255-024-01033-8).
- Brown adipocytes have the ability to convert foods into heat through a process called non-shivering thermogenesis.
- Activation of brown adipocytes can help in reducing body mass index (BMI) by increasing metabolic rates due to the release of noradrenaline.
- Researchers have identified a cold-inducible promoter that generates a truncated version of the enzyme adenylate cyclase 3, called Adcy3-at, which reduces the pool of adenylyl cyclases available for cAMP synthesis, driving lipolysis in brown fat cells.
- Mice genetically lacking AC3-AT protein were found to be protected from becoming obese and had increased lean mass.
- The discovery opens up the possibility of developing therapeutics to safely activate brown fat cells and combat obesity.
Conclusion:
The discovery of a mechanism to safely activate brown fat cells could revolutionize obesity research. If this principle can be applied in humans, it could lead to the development of long-term therapeutics for obesity. Further research is needed to explore the therapeutic impact of alternative gene products and their regulatory mechanisms in brown adipose tissue activation.
